Latest News

MEDICAL NEWS
POSTED BY CARA SCHILLINGER ON 4/7/2012

France's Transparency Commission (CT) Issues Favorable Opinion for Reimbursement of EsbrietĀ® (pirfenidone)

-- InterMune expresses confidence in ASCEND Phase 3 study outcome; updates timeline --
-- Company to conduct conference call and webcast at 4:30 p.m. EDT today --